The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

NCT02349685 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

219

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Infection

Interventions

PROCEDURE: H. pylori culture and antimicrobial susceptibility test
DRUG: 14 day PBMT group
DRUG: 14 day MEA group

Sponsor

Seoul National University Bundang Hospital